HYPERURICEMIA IN PATIENTS WITH GOUT: 40 MG OR 80 MG ONCE DAILY.
THE RECOMMENDED STARTING DOSE IS 40 MG ONCE DAILY. FOR PATIENTS WHO DO NOT ACHIEVE A SERUM URIC ACID LESS THAN 6 MG PER DL AFTER 2 WEEKS WITH 40 MG, ULORIC 80 MG IS RECOMMENDED.
GOUT FLARES MAY OCCUR AFTER INITIATION OF FEBUXOSTAT DUE TO CHANGING SERUM URIC ACID LEVELS RESULTING IN MOBILIZATION OF URATE FROM TISSUE DEPOSITS. FLARE PROPHYLAXIS WITH A NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) OR COLCHICINE IS RECOMMENDED UPON INITIATION OF ULORIC. PROPHYLACTIC THERAPY MAY BE BENEFICIAL FOR UP TO SIX MONTHS